Document is current
Any future updates will be listed below
-
Authors
Watson, Catherine H. https://orcid.org/0000-0002-4200-6502
Broadwater, Gloria
Wong, Janice
Spinosa, Daniel
de Oca, Mary Katherine Montes
Datto, Michael
Green, Michelle
Hubbard, Christopher
McKinney, Matthew
McCall, Shannon J.
Havrilesky, Laura J.
Strickler, John H.
Berchuck, Andrew
Strickland, Kyle C.
Previs, Rebecca A.
- License Information
-
More Information
Article History
Accepted: 10 December 2020
First Online: 5 January 2021
Declarations
:
: No external funding was used in the preparation of this article.
: Daniel Spinosa has an equity interest in Invitae, his wife’s employer. Kyle Strickland is a consultant pathologist for Foundation Medicine Inc. and Almac Pharmaceuticals. Matthew McKinney is a consultant for Kite/Gilead, Seattle Genetics, Molecular Templates, BTG, Pharmacyclics, Verastem, Genentech, and Celgene.
: This study was approved by the Duke Institutional Review Board (Pro00102134).
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Conceptualization: CW and RP. Design and implementation: CW, RP, JW, DS, MKMO, MD, JS, CH, MG, SM, LH, MM, KS. Analysis of results: GB. Writing of the manuscript: CW, DS, MKMO, GB, and RP. All authors participated in the review and revisions of the final manuscript.
